Aon released their report commissioned by the Scheme Advisory Board, identifying potential issues surrounding the participation of Tier 3 employers in the LGPS. We’ve set out some of the key issues and findings.
The LGPS SAB released their latest report on 22 May, providing information on the status of the LGPS for its members, employers and any other bodies. We’ve shared key things for fund actuaries in the lead up to the 2019 valuation.
Louise Lau, Actuary, provides some initial thoughts around the options put forward in the Scottish LGPS structure consultation and asks: what are some of the considerations to be had and what would be the potential consequences of such changes?
April has been a busy month for us - producing accounting reports for hundreds of participating employers in the LGPS. Roisin McGuire, Associate in Public Sector Consulting, reports about SEDR and the change in approach taken in accounting assumptions this year.
Changes to Regulation 64 of the LGPS Regulations 2013 will offer greater flexibility. Annemarie Allen provides some insight on what has changed and what this means for scheme employers and administering authorities.
Question marks over our ability to predict the future provided two of the highlights of our recent annual pensions conference. Senior Partner Nick Salter explores...
For a recent survey, Barnett Waddingham gathered information on Solvency II capital requirements for longevity from eight internal model firms and we found significant variations in assumptions.
This blog post was written by Dave Grimshaw and Jon Palin who discussed and compared a range of methods for projecting future improvements in mortality at the IFoA’s Life Conference on 20 November. The session was aimed at delegates without specialist longevity expertise, who need to assess proposed assumptions.
Rewind to 1900 and infectious diseases were the second biggest cause of death in England and Wales. By 1960, deaths from infectious diseases were all but eradicated.
It is common knowledge that smoking is the primary catalyst for lung cancer, the second and sixth highest cause of death for males and females respectively in 2012 . However, male and female mortality has been affected differently by changing prevalence of smoking.